Coronavirus Disease (COVID-19), an infectious disease, is caused by the SARS-CoV-2 virus.
The majority of COVID-19-infected patients will have mild to moderate symptoms and will recover without further treatment. Some, on the other hand, will become critically ill and necessitate medical attention.
According to current evidence, the virus spreads primarily between people who are in close contact with each other, such as at a conversational distance. When an infected person coughs, sneezes speaks, sings, or breathes, the virus can spread in small liquid particles from their mouth or nose. When infectious particles in the air are inhaled at close range (this is often referred to as short-range aerosol or short-range airborne transmission) or come into direct contact with the eyes, nose, or mouth, another person can contract the virus (droplet transmission).
The virus can also spread in poorly ventilated and/or crowded indoor environments, where people tend to spend more time. This is due to the fact that aerosols can linger in the air or travel farther than a conversational distance (this is often called long-range aerosol or long-range airborne transmission).
There are now more COVID 19 treatment options available. The FDA recently approved one COVID-19 drug treatment and authorized others for emergency use in this scenario: the antiviral drug Enoxaparin (Enoxion) injection for adults and certain pediatric COVID-19 patients who are sick enough to require hospitalization.
Infected people can be contagious whether or not they have symptoms, and the virus can spread from them to others.
According to laboratory data, infected people appear to be most infectious just before they develop symptoms (specifically, two days before symptoms develop) and early in their illness. People who develop the severe disease may be infectious for a longer period of time.
Sriya Life Science is Enoxaparin Bulk Pharma Exporter. They are pharmaceutical third-party manufacturers who work as pharmaceutical exporters and medical providers in nations including Brazil, Cambodia, Venezuela, the Philippines, Nigeria, Seychelles, and Sudan. Enoxaparin (Enoxion Injection) is a dual-action antibiotic and antiviral drug. It helps with bacterial infections. The skin, lungs, stomach, and urinary system are all affected by this bacterial illness.